next move, page-24

Where is growth going to come from? PBS spending is under the pump from the government, Accellerated price disclosure continues to bite with next round of cuts in October again larger than everyone thought. Cso is fixed for the next 5 years with no indexation. biosimilars are next kids off the block and may lead to high price items being supplied direct from generic manufacturers.... These are all external risks that I see to a very well run company in a sector with thin margins